In conclusion, the TLR4-mediated MyD88-dependent signaling pathway is probably one of the APS-induced signal pathways underlying the immunoregulation and anti-tumor effects of APS both in vitro and in vivo. This evidence concerns the gene TLR4 and neoplasm.